Finance

Lists
Q1 2027 earnings • released • Revenue miss -1.01%
See results
2264:TYO
Morinaga Milk Industry Co Ltd
Â¥1,195.00
-3.78%
(-47.00) 1D
Aug 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2264...
Open
Â¥1,170
High
Â¥1,210
Low
Â¥1,153
Mkt. cap
411.94B
Avg. vol.
1.92M
Volume
3.32M
Dividend
2.09%
Quarterly dividend
Â¥6
Ex-dividend date
Sep 29, 2026
P/E ratio
17.40
52-wk high
Â¥1,368
52-wk low
Â¥796
EPS
Â¥69
Shares outstanding
49.48M
No. of employees
7K
Open
Â¥1,170
High
Â¥1,210
Low
Â¥1,153
Mkt. cap
411.94B
Avg. vol.
1.92M
Volume
3.32M
Dividend
2.09%
Quarterly dividend
Â¥6
Ex-dividend date
Sep 29, 2026
P/E ratio
17.40
52-wk high
Â¥1,368
52-wk low
Â¥796
EPS
Â¥69
Shares outstanding
49.48M
No. of employees
7K
News stories
From web sources and news partners
Profile
Morinaga Milk Industry Co., Ltd. is a milk products and sweets company based in Tokyo, Japan, in operation since September 1, 1917. Their products include milk products, drinks, candy, confectioneries, and infant formula. Morinaga has distribution agreements with Mondelez International and Kalbe Farma. Its subsidiaries include Morinaga Hokuriku Dairy. Morinaga Milk celebrated its 100th anniversary in 2017. In addition to condensed milk and infant formula, products that it has offered since its founding, it has also produced a wide range of products based on milk, including Morinaga Milk, Bifidus Yogurt, Creap, and Mt. RAINIER CAFFE LATTE. Wikipedia
About Morinaga Milk Industry Co Ltd
CEOMichio Miyahara
Employees7.34K
FoundedSep 1, 1917
Headquarters-
SectorFood
Websitemorinagamilk.co.jp
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
147.10B / 148.60B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
149.65B
144.49B
133.64B
147.10B
Cost of goods sold
110.52B
107.34B
101.40B
110.96B
Cost of revenue
110.52B
107.34B
101.40B
110.96B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.17B
27.28B
28.41B
26.17B
Operating expense
27.17B
27.28B
28.44B
26.17B
Total operating expenses
137.68B
134.62B
129.84B
137.12B
Operating income
11.97B
9.88B
3.80B
9.98B
Other non operating income
354.00M
11.00M
891.00M
-5.00M
EBT including unusual items
10.72B
10.22B
783.00M
10.47B
EBT excluding unusual items
12.75B
10.92B
4.89B
10.61B
Income tax expense
2.97B
2.76B
49.00M
3.63B
Effective tax rate
27.70%
26.98%
6.26%
34.65%
Other operating expenses
-
-
-
-
Net income
7.73B
7.30B
663.00M
6.68B
Net profit margin
5.16%
5.05%
0.50%
4.54%
Earnings per share
-
-
-
-
Interest and investment income
319.00M
256.00M
225.00M
594.00M
Interest expense
-347.00M
-468.00M
-456.00M
-394.00M
Net interest expenses
-28.00M
-212.00M
-231.00M
200.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
17.84B
16.04B
9.77B
15.95B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps